Buenos Aires, August 8th. “Why I didn’t buy last week?”, an agricultural advisor laments himself today, viewing how the Bioceres stock rise and rise. A few weeks ago, the ticker touched a US$4 floor. Today, after know that the USDA approved the HB4 technology for soybean, the ticker is touching AR$7 per stock. “There is so much potential here”, finance consultant Ariel Sbdar tweeted today, when the ticker marked US$6.75. “Bioceres $BIOX is my large tenure in ARGY”, he adds. “In June, they killed me if I recommended buying $BIOX”, he ironizes in the social network.
(A work in progress, meanwhile we are waiting for the official press release)